Characterization of a human small-cell lung cancer cell line resistant to a new water-soluble camptothecin derivative, DX-8951f

Japanese Journal of Cancer Research

Volumn 89, Issue 11, 1998, Pages 1179-1186

  Nomoto, Taisuke ^a,b   Nishio, Kazuto ^a   Ishida, Tomoyuki ^a   Mori, Masatomo ^b   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Camptothecin; Drug resistance; DX 8951f; Lung cancer; Topoisomerase I

Indexed keywords

CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; CISPLATIN; DNA TOPOISOMERASE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; PRIORITY JOURNAL;

EID: 0032440216     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00513.x     Document Type: Article

References (25)

1. Wang, J. C. DNA topoisomerase Annu. Rev. Biochem., 65, 635-692 (1996).
2. Chen, A. Y. andLiu, L. F. Topoisomerases: essential enzymes and lethal targets. Anna. Rev. Biochem., 34, 191-218 (1989).
3. D'Arpa, P., Beardmore, C. andLiu L. F. Involvement of nucleic acid synthesis in cell killing mechanisms of Topo poisons. Cancer Res., 50, 6919-6924 (1990).
4. Hsiang, Y.-H., Hertzberg, R., Hecht, S. andLiu, L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA Topo I. J. Biol. Chem., 260, 14873-14878 (1985).
5. Kaneda, N., Nagata, H., Furuta, T. andYokokura, T. Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. Cancer Res., 50, 1715-1720 (1990).
6. Kingsbury, W. D., Boehm, J. C., Jakas, D. R., Holden, K. G., Hecht, S. M., Gallagher, G., Caranfa, M. J., McCabe, F. L., Faucette, L. F., Johnson, R. K. andHertzberg, R. P. Synthesis of water-soluble (aminoalkyl) camptothecin analogues: inhibition of Topo I and antitumor activity. J. Med. Chem., 34, 98-107 (1990).
7. Giovanella, B. C., Stehlin, J. S., Wall, M. E., Wani, M. C., Nicholas, A. W., Liu, L. F., Silber, R. S. andPotmesil, M. DNA Topo I targeted chemotherapy of human colon cancer in xenografts. Science, 246, 1046-1048 (1989).
8. Fukuoka, M., Niitani, H., Suzuki, A., Motomiya, M., Hasegawa, K., Nishiwaki, Y., Kuriyama, T., Ariyoshi, Y., Negoro, S., Masuda, N., Nakajima, S. andTaguchi, T. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J. Clin. Oncol., 10, 16-20 (1992).
9. Ohno, R., Okada, K., Masaoka, T., Kuramoto, A., Arima, T., Yoshida, Y., Ariyoshi, H., Ishimaru, M., Sakai, Y., Oguro, M., Ito, Y., Morishima, Y., Yokomaku, S. andOta, K. An early of CPT-11, for the treatment of leukemia and lymphoma. J. Clin. Oncol., 8, 1907-1912 (1990).
10. Taguchi, T., Makui, A. andHasegawa, K. Phase I clinical study of CPT-11. Jpn. J. Cancer Chemother., 17, 115-120 (1990) (in Japanese).
11. Mitsui, I., Kumazawa, E., Hirota, Y., Aonuma, M., Sugimori, M., Ohsuki, S., Uoto, K., Ejima, A., Terasawa, H. andSato, K. A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo. Jpn. J. Cancer Res., 86, 776-782 (1995).
12. Creemers, G. J., Lund, B. andVerweij, J. Topoisomerase I inhibitors: topotecan and irinotecan. Cancer Treat. Rev., 20, 73-96 (1994).
13. Potmesil, M. Camptothecins: from bench research to hospital wards. Cancer Res., 54, 1431-1439 (1994).
14. Pommier, Y., Tanizawa, A., Okada, K. andAndoh, T. Cellular determinants of sensitivity and resistance to camptothecins. In "Camptothecins: New Anticancer Agents," ed. M. Potmesil and H. Pinedo, pp. 123-138 (1995). CRC Press, Boca Raton.
15. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55-63 (1983).
16. Tsuruo, T., Iida-Saito, H., Kawabata, H., Oh-hara, T., Hamada, H. andUtakoji, T. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn. J. Cancer Res., 77, 682-692 (1986).
17. Horichi, N., Tapiero, H., Sugimoto, Y., Bungo, M., Nishiyama, M., Fourcade, A., Lampidis, T. J., Kasahara, K., Sasaki, Y., Takahashi, T. andSaijo, N. 3′-Deamino-3′morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks. Cancer Res., 50, 4698-4701 (1990).
18. Deffie, A. M., Batra, J. K. andGoldenberg, G. J. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. Cancer Res., 49, 58-62 (1989).
19. Liu, L. F. andMiller, K. G. Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc. Natl. Acad. Sci. USA, 78, 3487-3491 (1981).
20. Ogasawara, H., Nishio, K., Kanzawa, F., Lee, Y.-S., Funayama, Y., Ohira, T., Kuraishi, Y., Isogai, Y. andSaijo, N. Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11. Jpn. J. Cancer Res., 86, 124-130 (1995).
21. Emerson, D. L., Besterman, J. M., Brown, H. R., Evans, M. G., Leitner, P. P., Luzzio, M. J., Shaffer, J. E., Sternbach, D. D., Uehling, D. andVuong, A. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Cancer Res., 55, 603-609 (1995).
22. Mattern, M. R., Hofmann, G. A., Polsky, R. M., Funk, L. R., McCabe, F. L. and Johnson, R. K. In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells. Oncol. Res., 5, 467-474 (1993).
23. Kijima, T., Kubota, N. andNishio, K. Establishment of a CPT-11-resistant human ovarian cancer cell line. Anticancer Res., 14, 799-803 (1994).
24. Jansen, W. J., Zwart, B., Hulscher, S. T., Giaccone, G., Pinedo, H. M. andBoven, E. CPT-11 in human colon-cancer cell lines and xenografts: characterization of cellular sensitivity determinants. Int. J. Cancer, 70, 335-340 (1997).
25. Goldwasser, F., Bae, L, Valenti, M., Torres, K. andPommier, Y. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute antitumor screen. Cancer Res., 55, 2116-2121 (1995).